Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis E

M A Purdy1, K Krawczynski

  • 1Hepatitis Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Gastroenterology Clinics of North America
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The nuclear DICER-circular RNA complex drives the deregulation of the glioblastoma cell microRNAome.

Science advances·2020
Same author

Hepatitis E Virus and Related Viruses in Animals.

Transboundary and emerging diseases·2015
Same author

Effect of oestrus synchronization with PGF2α/eCG/hCG on luteal P4 synthesis in early pregnant gilts.

Reproduction in domestic animals = Zuchthygiene·2014
Same author

The novel effect of hCG administration on luteal function maintenance during the estrous cycle/pregnancy and early embryo development in the pig.

Polish journal of veterinary sciences·2013
Same author

In situ detection of hepatitis C viral antigens.

Methods in molecular medicine·2011
Same author

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.

Vaccine·2009
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

New diagnostic tests enhance understanding of Hepatitis E virus (HEV) infection, revealing long-lasting immunity and potential for vaccines. HEV is a common cause of acute hepatitis in children in endemic areas.

Area of Science:

  • Virology
  • Hepatology
  • Immunology

Background:

  • Hepatitis E virus (HEV) is a significant cause of acute hepatitis globally.
  • Understanding HEV pathogenesis and long-term immunity has been limited.
  • Diagnostic challenges have historically complicated HEV diagnosis.

Purpose of the Study:

  • To enhance the understanding of Hepatitis E virus (HEV) pathogenesis and immune responses.
  • To investigate the prevalence of HEV in pediatric populations.
  • To explore the potential for developing a recombinant vaccine against HEV.

Main Methods:

  • Utilized new, noncommercial diagnostic tests for HEV detection.
  • Delineated the process of pathogenesis in infected humans.
  • Analyzed IgG response to HEV for long-lasting immunity.

Related Experiment Videos

Main Results:

  • New diagnostic tests have greatly enhanced the understanding of HEV.
  • HEV is the most common cause of acute sporadic hepatitis in pediatric populations in endemic regions.
  • An IgG response to HEV is long-lasting and may confer immunity.

Conclusions:

  • Advances in diagnostics are improving HEV understanding and management.
  • HEV poses a significant public health challenge, particularly in pediatric populations.
  • The potential for a recombinant HEV vaccine is promising, pending further development and commercial availability.